Injured tissues require robust blood supply to deliver oxygen, nutrients, and immune cells necessary for repair
While human clinical trials remain limited, the existing body of evidence suggests BPC-157 may offer significant benefits for injury recovery, gut health, and tissue regeneration when used under proper medical supervision
First, they come from different populations and trial designs than the cagrilintide studies SURPASS-2 compared tirzepatide with semaglutide in diabetes
Sergey Terushkin, MD, FACS Meet with a provider either in person or through a secure telehealth appointment
Long-term safety data on the combination of cagrilintide and tirzepatide is lacking, and more research is needed to fully understand the potential risks and benefits of this approach